Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats

Fig. 2

Kaplan–Meier survival curves of SBTx recipients. Median recipient survival times were 10, 15, 14, and 24 days, in the allogeneic control (Allo) , BMMSC-treated, Ad/BMMSC-treated, and Ad/HO-1/BMMSC-treated groups, respectively (n = 5 in each group). Survival rates were significantly improved in the Ad/HO-1/BMMSC treatment group compared with the control groups (P = 0.0018 vs allogeneic control group; P = 0.0088 vs BMMSC-treated group; P = 0.0333 vs Ad/BMMSC-treated group). Ad adenoviral vector, BMMSC bone marrow mesenchymal stem cell, HO-1 heme oxygenase-1, SBTx small bowel transplantation

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512